12 August 2024
12 August 2024
As antibody drug conjugate (ADC)-centred deals dominate the oncology space, biotechs are using newer targets and linkers to differentiate themselves.
Days after competitor Novo Nordisk posted underwhelming Wegovy sales, Eli Lilly cited 鈥渟trong performance鈥� for Zepbound and Mounjaro.
The company stock was down by over 22.7% in premarket trading as AN2 shared trial termination plans for epetraborole.
Eque-cel received marketing approval from China's National Medical Products Administration in June 2023.
SBL-001 and SBL-002 are designed to significantly diminish fat cell volume.
The approval of neffy is supported by data from four clinical studies involving 175 healthy adults.
For an upfront payment of $700m, MSD will gain access to the CD3 and CD19-targeting bispecific antibody CN201.
Eladynos is a synthetic peptide analogue of parathyroid hormone-related protein (PTHrP) used to increase bone density.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
GlobalData's latest report offers a comprehensive analysis of the pharmaceutical packaging market, including a thorough segmentation by material such as glass, plastic, paper & paperboard, metals, and rubber further segmented by packaging type including primary, primary outers, and transport packaging. It also offers an additional segmentation by distribution channel including prescription drugs and OTC drugs. Per our estimates, the pharmaceutical packaging market was valued at $127.0 billion in 2023 and is expected to grow at a CAGR of >6% by 2030.
Give your business an edge with our leading industry insights.
